RUNX3 and neoplasm: Further, although the B16-F10 mock control cells demonstrated a high potential of pulmonary metastasis, as expected [57], the metastatic potential was abolished by Runx3, whereas subcutaneous tumor formation was reduced by Runx3 to 61.5% compared to the mock control cells (Figure 1C,D).